首页 > 最新文献

其他最新文献

英文 中文
IF:
Identification of a postoperative survival scoring index for adult liver transplantation.
Pub Date : 2025-12-01 Epub Date: 2025-02-04 DOI: 10.1080/07853890.2025.2458212
Shuai Wang, Xiaohong Lin, Yefu Li, Zhonghao Xie, Ming Zhang, Yicheng Liang, Chuchen Zhu, Yuqi Dong, Ping Zeng, Xiaoshun He, Weiqiang Ju, Maogen Chen

Background: In addition to surgical technology, successful liver transplantation (LT) depends on perioperative management, which needs an effective prognostic index. Therefore, a simplified and sensitive postoperative index for adult LT should be developed.

Methods: In total, 906 patients who underwent LT were included in this cross-sectional study. Univariate analysis was used to identify the independent risk factors for recipient survival. Multivariate logistic and stepwise regression analyses were used to construct and simplify the model design. Area under the curve (AUC) and Kaplan-Meier's (K-M) analysis demonstrated superiority of the new index. The postoperative survival score (POSS) index was further simplified via restricted cubic spline (RCS) analysis. Finally, the interpretation of the long-term mortality and subgroup analyses extended the application of the POSS index.

Results: Finally, a total of five factors (donor sex, recipient body mass index (BMI), total bilirubin (Tbil), international normalized ratio (INR) and total operative time) were identified as independent risk parameters and included in our POSS index. The AUCs of the original and simplified POSS indices were 0.764 and 0.723, respectively. Patients with high scores had poor short-term survival. Our index also functioned well in predicting long-term mortality, and it was more effective for patients with hepatitis B cirrhosis or hepatocellular carcinoma (HCC).

Conclusions: We constructed a simplified and effective postoperative survival scoring index to predict short-term complications and survival in adult LT patients.

{"title":"Identification of a postoperative survival scoring index for adult liver transplantation.","authors":"Shuai Wang, Xiaohong Lin, Yefu Li, Zhonghao Xie, Ming Zhang, Yicheng Liang, Chuchen Zhu, Yuqi Dong, Ping Zeng, Xiaoshun He, Weiqiang Ju, Maogen Chen","doi":"10.1080/07853890.2025.2458212","DOIUrl":"10.1080/07853890.2025.2458212","url":null,"abstract":"<p><strong>Background: </strong>In addition to surgical technology, successful liver transplantation (LT) depends on perioperative management, which needs an effective prognostic index. Therefore, a simplified and sensitive postoperative index for adult LT should be developed.</p><p><strong>Methods: </strong>In total, 906 patients who underwent LT were included in this cross-sectional study. Univariate analysis was used to identify the independent risk factors for recipient survival. Multivariate logistic and stepwise regression analyses were used to construct and simplify the model design. Area under the curve (AUC) and Kaplan-Meier's (K-M) analysis demonstrated superiority of the new index. The postoperative survival score (POSS) index was further simplified via restricted cubic spline (RCS) analysis. Finally, the interpretation of the long-term mortality and subgroup analyses extended the application of the POSS index.</p><p><strong>Results: </strong>Finally, a total of five factors (donor sex, recipient body mass index (BMI), total bilirubin (Tbil), international normalized ratio (INR) and total operative time) were identified as independent risk parameters and included in our POSS index. The AUCs of the original and simplified POSS indices were 0.764 and 0.723, respectively. Patients with high scores had poor short-term survival. Our index also functioned well in predicting long-term mortality, and it was more effective for patients with hepatitis B cirrhosis or hepatocellular carcinoma (HCC).</p><p><strong>Conclusions: </strong>We constructed a simplified and effective postoperative survival scoring index to predict short-term complications and survival in adult LT patients.</p>","PeriodicalId":93874,"journal":{"name":"Annals of medicine","volume":"57 1","pages":"2458212"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795760/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143190470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An overview of downhill esophageal varices: a challenge for medical practice.
Pub Date : 2025-12-01 Epub Date: 2025-02-04 DOI: 10.1080/07853890.2025.2462452
Donghong Wang, Zhibin Ma

Objectives: Unlike the commonly seen uphill esophageal varices in clinical practice, downhill esophageal varices are caused by obstruction of the superior vena cava and azygous venous system. The predominant causes of downhill esophageal varices are hemodialysis in end-stage renal disease patients and mediastinal malignancies. The cornerstone of the treatment for downhill esophageal varices is to address the underlying primary causes. Without this, patients may suffer from recurrent bleeding, and the bleeding can be fatal.

Methods: This review is primarily summarized through previous case reports. Meanwhile, it emphasizes the significance of case reports.

Results: Clinicians should be conscious that esophageal varices are not necessarily caused by liver cirrhosis or non-cirrhotic portal hypertension.

Conclusions: Specifically, when varices are only observed in the upper and middle esophagus, and the patient presents with evidence of superior vena cava obstruction, clinicians should be particularly vigilant for downhill esophageal varices. Moreover, a thorough investigation and definitive treatment of the underlying primary causes should be implemented.

{"title":"An overview of downhill esophageal varices: a challenge for medical practice.","authors":"Donghong Wang, Zhibin Ma","doi":"10.1080/07853890.2025.2462452","DOIUrl":"10.1080/07853890.2025.2462452","url":null,"abstract":"<p><strong>Objectives: </strong>Unlike the commonly seen uphill esophageal varices in clinical practice, downhill esophageal varices are caused by obstruction of the superior vena cava and azygous venous system. The predominant causes of downhill esophageal varices are hemodialysis in end-stage renal disease patients and mediastinal malignancies. The cornerstone of the treatment for downhill esophageal varices is to address the underlying primary causes. Without this, patients may suffer from recurrent bleeding, and the bleeding can be fatal.</p><p><strong>Methods: </strong>This review is primarily summarized through previous case reports. Meanwhile, it emphasizes the significance of case reports.</p><p><strong>Results: </strong>Clinicians should be conscious that esophageal varices are not necessarily caused by liver cirrhosis or non-cirrhotic portal hypertension.</p><p><strong>Conclusions: </strong>Specifically, when varices are only observed in the upper and middle esophagus, and the patient presents with evidence of superior vena cava obstruction, clinicians should be particularly vigilant for downhill esophageal varices. Moreover, a thorough investigation and definitive treatment of the underlying primary causes should be implemented.</p>","PeriodicalId":93874,"journal":{"name":"Annals of medicine","volume":"57 1","pages":"2462452"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795747/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143191618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examined lymph node counts affected the staging and survival in cervical cancer: a retrospective study using the SEER and Chinese cohort.
Pub Date : 2025-12-01 Epub Date: 2025-02-03 DOI: 10.1080/07853890.2025.2459821
Tao Guo, Yuxi Zhao, Jia Zeng, Jian Li, Enyu Tang, Lingying Wu

Background: The impact of examined lymph node (LN) count on survival in cervical cancer remains understudied, with no consensus on the optimal number required.

Objectives: We aimed to investigate the role of LN count in postoperative pathological evaluation for cervical cancer patients undergoing surgery.

Methods: Data from the US SEER database and a retrospective Chinese cohort were analyzed. Multivariable logistic and Cox regression models assessed LN positivity detection and overall survival (OS), respectively. Smoothing spline curves and Chow tests identified structural change points in hazard ratios and LN-positive ratios.

Results: Among 14,133 SEER and 2,811 Chinese cases, higher LN counts correlated with increased detection of positive LNs (OR: 1.040, 95% CI: 1.019-1.062) and improved OS (HR: 0.990, 95% CI: 0.984-0.996). Structural change points occurred at 20 LNs for LN-negative patients and 13 LNs for LN-positive patients (both P < 0.001). An elevated LN-positive ratio (positive/examined LNs) strongly predicted worse OS (HR: 4.208; 95% CI: 1.454-12.181).

Conclusions: An increased number of examined LNs significantly contributes to the detection of positive LNs and improved patient survival. For patients with claimed LN-negative and LN-positive disease, a minimum examination of 20 and 13 LNs, respectively, is recommended to ensure adequate LN evaluation. The LN positive ratio is a strong prognostic indicator in patients with LN-positive disease.

{"title":"Examined lymph node counts affected the staging and survival in cervical cancer: a retrospective study using the SEER and Chinese cohort.","authors":"Tao Guo, Yuxi Zhao, Jia Zeng, Jian Li, Enyu Tang, Lingying Wu","doi":"10.1080/07853890.2025.2459821","DOIUrl":"10.1080/07853890.2025.2459821","url":null,"abstract":"<p><strong>Background: </strong>The impact of examined lymph node (LN) count on survival in cervical cancer remains understudied, with no consensus on the optimal number required.</p><p><strong>Objectives: </strong>We aimed to investigate the role of LN count in postoperative pathological evaluation for cervical cancer patients undergoing surgery.</p><p><strong>Methods: </strong>Data from the US SEER database and a retrospective Chinese cohort were analyzed. Multivariable logistic and Cox regression models assessed LN positivity detection and overall survival (OS), respectively. Smoothing spline curves and Chow tests identified structural change points in hazard ratios and LN-positive ratios.</p><p><strong>Results: </strong>Among 14,133 SEER and 2,811 Chinese cases, higher LN counts correlated with increased detection of positive LNs (OR: 1.040, 95% CI: 1.019-1.062) and improved OS (HR: 0.990, 95% CI: 0.984-0.996). Structural change points occurred at 20 LNs for LN-negative patients and 13 LNs for LN-positive patients (both P < 0.001). An elevated LN-positive ratio (positive/examined LNs) strongly predicted worse OS (HR: 4.208; 95% CI: 1.454-12.181).</p><p><strong>Conclusions: </strong>An increased number of examined LNs significantly contributes to the detection of positive LNs and improved patient survival. For patients with claimed LN-negative and LN-positive disease, a minimum examination of 20 and 13 LNs, respectively, is recommended to ensure adequate LN evaluation. The LN positive ratio is a strong prognostic indicator in patients with LN-positive disease.</p>","PeriodicalId":93874,"journal":{"name":"Annals of medicine","volume":"57 1","pages":"2459821"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11792132/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143082554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heterologous expression of SpsTAC2 in Arabidopsis affected branch angle and secondary vascular system development.
Pub Date : 2025-12-01 Epub Date: 2025-02-05 DOI: 10.1080/15592324.2025.2450821
Fangshu Niu, Mengru Yuan, Hongxia Zhao, Zhi Pang, Jie Yan, RuiXie Ning, Lin Shi, Fengqiang Yu, Dongshan Wei, Rong Yang, Runming Zhang, Haifeng Yang

To investigate the biological functions of Tiller Angle Control 2 (TAC2) in Salix psammophila. In this study, TAC2 was cloned from Salix psammophila, and an overexpression and subcellular localization expression vector for the SpsTAC2 gene was constructed. The SpsTAC2 gene was overexpressed in Arabidopsis and analyzed for phenotypic changes. The subcellular localization of SpsTAC2 was analyzed via Agrobacterium-mediated transient expression in onion (Allium cepa L.) epidermal cells. Phenotypic characterization of SpsTAC2 overexpressing Arabidopsis strains revealed that the branching angle of the transgenic strains was significantly greater than that of the wild type, and the anatomical structures of the stems and hypocotyls of the transgenic strains indicated that the vascular system of the transgenic strains developed more slowly than did that of the wild type. The subcellular localization of the SpsTAC2 gene revealed that the localization signals of the SpsTAC2 gene were mainly in the nucleus, and weak signals also appeared in the cell membrane, suggesting that the SpsTAC2 gene was mainly expressed mainly in the nucleus, with a small amount of expression in the cell membrane. This findings suggest that the SpsTAC2 gene influences the development of the branching angle of plants and xylem, and exerts its effects mainly in the nucleus and membrane. This study can help to characterize the regulatory effect of the TAC gene on the branching angle and explore its effect on the branching angle and vascular system development, and also help to explore the possible molecular regulatory mechanism, which can provide a theoretical basis for further elucidation of the mechanism of action of the IGT gene family.

{"title":"Heterologous expression of <i>SpsTAC2</i> in Arabidopsis affected branch angle and secondary vascular system development.","authors":"Fangshu Niu, Mengru Yuan, Hongxia Zhao, Zhi Pang, Jie Yan, RuiXie Ning, Lin Shi, Fengqiang Yu, Dongshan Wei, Rong Yang, Runming Zhang, Haifeng Yang","doi":"10.1080/15592324.2025.2450821","DOIUrl":"10.1080/15592324.2025.2450821","url":null,"abstract":"<p><p>To investigate the biological functions of <i>Tiller Angle Control 2</i> (<i>TAC2</i>) in <i>Salix psammophila</i>. In this study, <i>TAC2</i> was cloned from <i>Salix psammophila</i>, and an overexpression and subcellular localization expression vector for the <i>SpsTAC2</i> gene was constructed. The <i>SpsTAC2</i> gene was overexpressed in Arabidopsis and analyzed for phenotypic changes. The subcellular localization of <i>SpsTAC2</i> was analyzed via <i>Agrobacterium</i>-mediated transient expression in onion (<i>Allium cepa L</i>.) epidermal cells. Phenotypic characterization of <i>SpsTAC2</i> overexpressing Arabidopsis strains revealed that the branching angle of the transgenic strains was significantly greater than that of the wild type, and the anatomical structures of the stems and hypocotyls of the transgenic strains indicated that the vascular system of the transgenic strains developed more slowly than did that of the wild type. The subcellular localization of the <i>SpsTAC2</i> gene revealed that the localization signals of the <i>SpsTAC2</i> gene were mainly in the nucleus, and weak signals also appeared in the cell membrane, suggesting that the <i>SpsTAC2</i> gene was mainly expressed mainly in the nucleus, with a small amount of expression in the cell membrane. This findings suggest that the <i>SpsTAC2</i> gene influences the development of the branching angle of plants and xylem, and exerts its effects mainly in the nucleus and membrane. This study can help to characterize the regulatory effect of the <i>TAC</i> gene on the branching angle and explore its effect on the branching angle and vascular system development, and also help to explore the possible molecular regulatory mechanism, which can provide a theoretical basis for further elucidation of the mechanism of action of the <i>IGT</i> gene family.</p>","PeriodicalId":94172,"journal":{"name":"Plant signaling & behavior","volume":"20 1","pages":"2450821"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11801345/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143191701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Utilizing vaginal natural orifice to facilitate bowel manipulation during totally intracorporeal ileal conduit construction: a retrospective cohort study. 一项回顾性队列研究:在全体内回肠管道构建过程中,利用阴道自然口促进肠道操作。
Pub Date : 2025-12-01 Epub Date: 2025-01-18 DOI: 10.1080/07853890.2025.2453827
Kaipeng Jia, Shiwang Huang, Zhun Wang, Yuda Lin, Yiduo Bai, Chong Shen, Zhe Zhang, Zhouliang Wu, Yunkai Qie, Hailong Hu

Objective: To explore the feasibility and efficacy of the modified technique of totally intracorporeal ileal conduit (IC) construction via vaginal approach following robot-assisted radical cystectomy (RARC) in females.

Methods: By comparing the perioperative outcomes of the modified technique with extracorporeal urinary diversion (ECUD), 31 females treated for bladder cancer with RARC and IC from May 2020 to December 2023 were retrospectively analyzed and divided into two groups: the ECUD group (10 patients) and the modified intracorporeal urinary diversion (MICUD group) (21 patients). The modified technique involved performing transvaginal natural orifice specimen extraction surgery (TV-NOSES) after RARC; followed by the transvaginal placement of an Endo-GIA stapler to manipulate the bowel for intracorporeal IC construction.

Results: Both groups' surgeries were successfully completed by the same surgeon and team. Patients in the MICUD group had shorter total operative time, lower postoperative pain scores, quicker recovery, and shorter hospital stays. The learning curve of the MICUD showed two phases: a learning phase (cases 1-7) and a proficiency phase (cases 8-21). The incidence of postoperative complications between the two groups was similar. The mean follow-up times were 29.3 months (ECUD group) and 22.6 months (MICUD group). In the MICUD group, there was one case of local tumor recurrence, two cases of distant metastasis, including one death from progression; in the ECUD group, one patient had distant metastasis and died from progression.

Conclusion: RARC with MICUD represents a safe, feasible and easy-to-learn minimally invasive surgical approach. Patients experience less trauma and faster recoveries.

目的:探讨机器人辅助根治性膀胱切除术(RARC)后经阴道入路全体内回肠导管(IC)改良技术的可行性和有效性。方法:回顾性分析2020年5月~ 2023年12月31例女性膀胱癌患者行RARC + IC术的围手术期疗效,分为ECUD组(10例)和改良体内导尿(MICUD组)2组(21例)。改良后的技术包括在RARC后进行经阴道自然孔标本提取手术(TV-NOSES);然后经阴道放置endogia吻合器来操纵肠道进行体内IC构建。结果:两组手术均由同一术者、同一小组顺利完成。MICUD组患者总手术时间较短,术后疼痛评分较低,恢复较快,住院时间较短。MICUD的学习曲线表现为两个阶段:学习阶段(病例1-7)和熟练阶段(病例8-21)。两组术后并发症发生率相似。ECUD组平均随访29.3个月,MICUD组平均随访22.6个月。MICUD组肿瘤局部复发1例,远处转移2例,其中进展死亡1例;在ECUD组中,1例患者发生远处转移并因进展而死亡。结论:RARC联合MICUD是一种安全、可行、易学的微创手术入路。患者的创伤更小,恢复更快。
{"title":"Utilizing vaginal natural orifice to facilitate bowel manipulation during totally intracorporeal ileal conduit construction: a retrospective cohort study.","authors":"Kaipeng Jia, Shiwang Huang, Zhun Wang, Yuda Lin, Yiduo Bai, Chong Shen, Zhe Zhang, Zhouliang Wu, Yunkai Qie, Hailong Hu","doi":"10.1080/07853890.2025.2453827","DOIUrl":"10.1080/07853890.2025.2453827","url":null,"abstract":"<p><strong>Objective: </strong>To explore the feasibility and efficacy of the modified technique of totally intracorporeal ileal conduit (IC) construction <i>via</i> vaginal approach following robot-assisted radical cystectomy (RARC) in females.</p><p><strong>Methods: </strong>By comparing the perioperative outcomes of the modified technique with extracorporeal urinary diversion (ECUD), 31 females treated for bladder cancer with RARC and IC from May 2020 to December 2023 were retrospectively analyzed and divided into two groups: the ECUD group (10 patients) and the modified intracorporeal urinary diversion (MICUD group) (21 patients). The modified technique involved performing transvaginal natural orifice specimen extraction surgery (TV-NOSES) after RARC; followed by the transvaginal placement of an Endo-GIA stapler to manipulate the bowel for intracorporeal IC construction.</p><p><strong>Results: </strong>Both groups' surgeries were successfully completed by the same surgeon and team. Patients in the MICUD group had shorter total operative time, lower postoperative pain scores, quicker recovery, and shorter hospital stays. The learning curve of the MICUD showed two phases: a learning phase (cases 1-7) and a proficiency phase (cases 8-21). The incidence of postoperative complications between the two groups was similar. The mean follow-up times were 29.3 months (ECUD group) and 22.6 months (MICUD group). In the MICUD group, there was one case of local tumor recurrence, two cases of distant metastasis, including one death from progression; in the ECUD group, one patient had distant metastasis and died from progression.</p><p><strong>Conclusion: </strong>RARC with MICUD represents a safe, feasible and easy-to-learn minimally invasive surgical approach. Patients experience less trauma and faster recoveries.</p>","PeriodicalId":93874,"journal":{"name":"Annals of medicine","volume":"57 1","pages":"2453827"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11748861/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A study to determine the effect of nano-selenium and thymoquinone on the Nrf2 gene expression in Alzheimer's disease.
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 Epub Date: 2025-01-31 DOI: 10.1080/20565623.2025.2458434
Doha El-Sayed Ellakwa, Laila Ahmed Rashed, Ola Sayed Ali, Noha Amr El-Sabbagh

Introduction: Alzheimer's disease is a developing public health concern in aging communities that affects a sizable section of the global population. The risk of Alzheimer's disease increases with age; it affects one-third of males and two-thirds of women. This research attempts to assess the effect of nano-selenium and thymoquinone on Nrf2 gene expression levels in Alzheimer's disease (AD).

Methods: There were five identical groups of 50 albino male rats: a control group that was healthy; an AD positive control group; an AD group that received nano-selenium (5 mg/kg); an AD group that received thymoquinone (2 mg/kg); and an AD group that received both. The duration of treatment was 4 weeks. The levels of Nrf2 in brain tissues were evaluated using real-time PCR.

Results: Nrf2 mean expression levels in the nano-selenium-treated rats, the thymoquinone-treated rats, and the rats that were given both treatments all increased significantly compared to AD rats with no treatment.

Conclusions: This study showed that nano-selenium and thymoquinone elevated Nrf2 gene expression levels in AD.

{"title":"A study to determine the effect of nano-selenium and thymoquinone on the Nrf2 gene expression in Alzheimer's disease.","authors":"Doha El-Sayed Ellakwa, Laila Ahmed Rashed, Ola Sayed Ali, Noha Amr El-Sabbagh","doi":"10.1080/20565623.2025.2458434","DOIUrl":"10.1080/20565623.2025.2458434","url":null,"abstract":"<p><strong>Introduction: </strong>Alzheimer's disease is a developing public health concern in aging communities that affects a sizable section of the global population. The risk of Alzheimer's disease increases with age; it affects one-third of males and two-thirds of women<sup>.</sup> This research attempts to assess the effect of nano-selenium and thymoquinone on Nrf2 gene expression levels in Alzheimer's disease (AD).</p><p><strong>Methods: </strong>There were five identical groups of 50 albino male rats: a control group that was healthy; an AD positive control group; an AD group that received nano-selenium (5 mg/kg); an AD group that received thymoquinone (2 mg/kg); and an AD group that received both. The duration of treatment was 4 weeks. The levels of Nrf2 in brain tissues were evaluated using real-time PCR.</p><p><strong>Results: </strong>Nrf2 mean expression levels in the nano-selenium-treated rats, the thymoquinone-treated rats, and the rats that were given both treatments all increased significantly compared to AD rats with no treatment.</p><p><strong>Conclusions: </strong>This study showed that nano-selenium and thymoquinone elevated Nrf2 gene expression levels in AD.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2458434"},"PeriodicalIF":2.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11792829/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143064779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reporting and representation of participant race and ethnicity in phase III clinical trials for solid tumors.
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 Epub Date: 2025-01-30 DOI: 10.1080/20565623.2025.2458415
Tianyi Wang, Dinorah J Villanueva, Ambily Banerjee, Dina Gifkins

Background: Including racial and ethnic minorities in clinical trials is essential for advancing health equity. Despite progress, trials often do not mirror patient population demographics.

Methods: The National Library of Medicine's Clinical Trials database was queried for phase III trials of lung, colorectal, breast, and prostate cancers. A reference population was identified from the Surveillance, Epidemiology, and End Result (SEER) database, covering 48% of the US population.

Results: Among 181 trials, race and ethnicity data were included in 86.7% and 60.2% of trials, respectively, with improving reporting over time. Participants were predominantly White (76.3%), followed by Asian/Pacific Islander (14.1%), Black/African American (4.5%), and American Indian/Alaska Native (0.6%). Hispanic/Latino constituted 6.4% of participants. The proportion of non-White groups increased from 19.4% in trials started before 2011 to 26.2% after 2015. Compared with SEER data, the percentages were lower for Asian/Pacific Islander across all cancers, Black/African American in breast and prostate cancers, American Indian or Alaska Native in colorectal, breast, and prostate cancers in US solely trials.

Conclusions: Reporting and enrollment of racial and ethnic minorities in trials remain inadequate but improving. To enhance diversity, real-world data are warranted to identify recruitment goals by better assessing the geographic distribution within the patient population.

{"title":"Reporting and representation of participant race and ethnicity in phase III clinical trials for solid tumors.","authors":"Tianyi Wang, Dinorah J Villanueva, Ambily Banerjee, Dina Gifkins","doi":"10.1080/20565623.2025.2458415","DOIUrl":"10.1080/20565623.2025.2458415","url":null,"abstract":"<p><strong>Background: </strong>Including racial and ethnic minorities in clinical trials is essential for advancing health equity. Despite progress, trials often do not mirror patient population demographics.</p><p><strong>Methods: </strong>The National Library of Medicine's Clinical Trials database was queried for phase III trials of lung, colorectal, breast, and prostate cancers. A reference population was identified from the Surveillance, Epidemiology, and End Result (SEER) database, covering 48% of the US population.</p><p><strong>Results: </strong>Among 181 trials, race and ethnicity data were included in 86.7% and 60.2% of trials, respectively, with improving reporting over time. Participants were predominantly White (76.3%), followed by Asian/Pacific Islander (14.1%), Black/African American (4.5%), and American Indian/Alaska Native (0.6%). Hispanic/Latino constituted 6.4% of participants. The proportion of non-White groups increased from 19.4% in trials started before 2011 to 26.2% after 2015. Compared with SEER data, the percentages were lower for Asian/Pacific Islander across all cancers, Black/African American in breast and prostate cancers, American Indian or Alaska Native in colorectal, breast, and prostate cancers in US solely trials.</p><p><strong>Conclusions: </strong>Reporting and enrollment of racial and ethnic minorities in trials remain inadequate but improving. To enhance diversity, real-world data are warranted to identify recruitment goals by better assessing the geographic distribution within the patient population.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2458415"},"PeriodicalIF":2.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11792851/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143064963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantum leadership: new approach in managing shoulder dystocia in simulation-based training.
IF 2.4 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2025-12-01 Epub Date: 2025-01-30 DOI: 10.1080/20565623.2025.2458427
Georges Yared, Christopher Massaad, Kariman Ghazal

Background: Shoulder dystocia, a challenging condition for obstetricians, poses significant risks to both maternal and neonatal health, including maternal postpartum hemorrhage, neonatal hypoxia, and brachial plexus injury. Despite being unpredictable and unpreventable, effective management can mitigate these risks. Miscommunication and poor leadership are responsible for 72% of medical errors, which further highlights the importance of robust leadership skills in obstetric emergencies.

Research design and methods: A qualitative study involving 20 participants through structured interviews assessed preferred leadership styles in managing shoulder dystocia.

Results: Findings revealed that 55% of participants favored quantum leadership. Other preferences included laissez-faire by one anesthesiologist and democratic by two midwives. However, all participants acknowledged the efficacy of the seven quantum leadership skills in managing shoulder dystocia. Discussion emphasized that traditional leadership styles are less effective compared to quantum leadership in managing the complexities of shoulder dystocia. The quantum Ob-Wheel, consisting of 12 milestones, integrates these seven interdependent skills to guide the management process.

Conclusions: Despite the limited sample size of this study, it is worth noting that, given the unpredictable nature of shoulder dystocia, clinicians should be prepared for its occurrence during any birth, with quantum leadership providing a strategic advantage in such scenarios.

{"title":"Quantum leadership: new approach in managing shoulder dystocia in simulation-based training.","authors":"Georges Yared, Christopher Massaad, Kariman Ghazal","doi":"10.1080/20565623.2025.2458427","DOIUrl":"10.1080/20565623.2025.2458427","url":null,"abstract":"<p><strong>Background: </strong>Shoulder dystocia, a challenging condition for obstetricians, poses significant risks to both maternal and neonatal health, including maternal postpartum hemorrhage, neonatal hypoxia, and brachial plexus injury. Despite being unpredictable and unpreventable, effective management can mitigate these risks. Miscommunication and poor leadership are responsible for 72% of medical errors, which further highlights the importance of robust leadership skills in obstetric emergencies.</p><p><strong>Research design and methods: </strong>A qualitative study involving 20 participants through structured interviews assessed preferred leadership styles in managing shoulder dystocia.</p><p><strong>Results: </strong>Findings revealed that 55% of participants favored quantum leadership. Other preferences included laissez-faire by one anesthesiologist and democratic by two midwives. However, all participants acknowledged the efficacy of the seven quantum leadership skills in managing shoulder dystocia. Discussion emphasized that traditional leadership styles are less effective compared to quantum leadership in managing the complexities of shoulder dystocia. The quantum Ob-Wheel, consisting of 12 milestones, integrates these seven interdependent skills to guide the management process.</p><p><strong>Conclusions: </strong>Despite the limited sample size of this study, it is worth noting that, given the unpredictable nature of shoulder dystocia, clinicians should be prepared for its occurrence during any birth, with quantum leadership providing a strategic advantage in such scenarios.</p>","PeriodicalId":12568,"journal":{"name":"Future Science OA","volume":"11 1","pages":"2458427"},"PeriodicalIF":2.4,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11792848/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143064987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of amniotic fluid on hair follicle growth. 羊水对毛囊生长的影响。
Pub Date : 2025-12-01 Epub Date: 2025-01-19 DOI: 10.1080/09546634.2025.2451389
Gamze Tumentemur, Elif Ganime Aygun, Bulut Yurtsever, Didem Cakirsoy, Ercument Ovali

Purpose: Human amniotic fluid stem cells (hAFSCs) have shown significant regenerative potential in treating hair loss, wound healing, and tissue repair. This study aims to evaluate the effects of human amniotic fluid (hAF) on hair follicle (HF) regeneration and immune system modulation.

Materials and Methods: The hAF used was pooled, acellular, and gamma-irradiated to standardize its contents and enhance its stability. Both irradiated (FAFI) and non-irradiated (FAF) hAF were assessed for their efficacy and safety in promoting hair growth and modulating immune responses in a rat model of hair loss. The study examined HF regeneration, transition to the anagen phase, and macrophage polarization from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype.

Results: Both FAF and FAFI treatments significantly increased HF density, with FAFI exhibiting enhanced effects. Histological analysis demonstrated improved HF regeneration, increased M2 macrophages, and reduced collagen fiber deposition in treated areas. Gamma irradiation likely improved the efficacy of FAFI by stabilizing active components and inhibiting protease activity.

Conclusions: Irradiated hAF is a safe and effective therapeutic candidate for alopecia and HF growth disorders. These findings support further evaluation of hAF in clinical trials to validate its potential for hair regeneration therapies.

目的:人羊水干细胞(hAFSCs)在治疗脱发、伤口愈合和组织修复方面显示出显著的再生潜力。本研究旨在探讨人羊水(hAF)对毛囊(HF)再生和免疫系统调节的影响。材料与方法:将所用hAF进行池化、脱细胞和γ辐照,以标准化其含量并增强其稳定性。在大鼠脱发模型中,研究人员评估了辐照(FAFI)和非辐照(FAF) hAF在促进毛发生长和调节免疫反应方面的有效性和安全性。该研究检测了HF的再生、向生长期的过渡以及巨噬细胞从促炎M1表型向抗炎M2表型的极化。结果:FAF和FAFI治疗均能显著提高HF密度,且FAFI效果更明显。组织学分析显示,治疗区HF再生改善,M2巨噬细胞增加,胶原纤维沉积减少。伽马辐射可能通过稳定活性成分和抑制蛋白酶活性来提高FAFI的疗效。结论:辐照hAF是治疗脱发和HF生长障碍的一种安全有效的治疗方法。这些发现支持在临床试验中进一步评估hAF,以验证其在头发再生治疗中的潜力。
{"title":"Effect of amniotic fluid on hair follicle growth.","authors":"Gamze Tumentemur, Elif Ganime Aygun, Bulut Yurtsever, Didem Cakirsoy, Ercument Ovali","doi":"10.1080/09546634.2025.2451389","DOIUrl":"https://doi.org/10.1080/09546634.2025.2451389","url":null,"abstract":"<p><p><b>Purpose:</b> Human amniotic fluid stem cells (hAFSCs) have shown significant regenerative potential in treating hair loss, wound healing, and tissue repair. This study aims to evaluate the effects of human amniotic fluid (hAF) on hair follicle (HF) regeneration and immune system modulation.</p><p><p><b>Materials and Methods:</b> The hAF used was pooled, acellular, and gamma-irradiated to standardize its contents and enhance its stability. Both irradiated (FAFI) and non-irradiated (FAF) hAF were assessed for their efficacy and safety in promoting hair growth and modulating immune responses in a rat model of hair loss. The study examined HF regeneration, transition to the anagen phase, and macrophage polarization from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype.</p><p><p><b>Results:</b> Both FAF and FAFI treatments significantly increased HF density, with FAFI exhibiting enhanced effects. Histological analysis demonstrated improved HF regeneration, increased M2 macrophages, and reduced collagen fiber deposition in treated areas. Gamma irradiation likely improved the efficacy of FAFI by stabilizing active components and inhibiting protease activity.</p><p><p><b>Conclusions:</b> Irradiated hAF is a safe and effective therapeutic candidate for alopecia and HF growth disorders. These findings support further evaluation of hAF in clinical trials to validate its potential for hair regeneration therapies.</p>","PeriodicalId":94235,"journal":{"name":"The Journal of dermatological treatment","volume":"36 1","pages":"2451389"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143019230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and epidemiological characteristics of respiratory syncytial virus, SARS-CoV-2 and influenza paediatric viral respiratory infections in southwest Saudi Arabia. 沙特阿拉伯西南部呼吸道合胞病毒、SARS-CoV-2和流感儿童病毒性呼吸道感染的临床和流行病学特征
Pub Date : 2025-12-01 Epub Date: 2024-12-24 DOI: 10.1080/07853890.2024.2445791
Ali Alsuheel Asseri, Saleh M Al-Qahtani, Ibrahim A Alzaydani, Ahmed Al-Jarie, Noha Saad Alyazidi, Ali A Alrmelawi, Alya Musfer Alqahtani, Rahaf S Alsulayyim, Ameerah K Alzailaie, Dhay M Abdullah, Abdelwahid S Ali

Background: There is a global consensus that respiratory tract infections are the major causes of morbidity and mortality among children. In this study, we aimed to compare the clinical and epidemiological characteristics of respiratory syncytial virus (RSV), influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections among children admitted to hospital with acute respiratory infections. We also opted to identify the predictors of paediatric intensive care unit (PICU) admission.

Methods: In this study, a retrospective investigation and analysis of 423 children who were admitted to Abha Maternity and Children Hospital, in the southern region of Saudi Arabia, between January and December 2022 were conducted.

Results: The median age of these children was 16.5 months (Q1-Q3: 6-46.3). It was observed that the infectivity levels of RSV, SARS-CoV-2, influenza A and influenza B infections peaked in early to mid-September, mid-July, May and June, and October, respectively. There was a statistically significant difference in the total WBC counts between RSV and influenza B (p = 0.035) and SARS-CoV-2 and influenza B (p = 0.013). Moreover, there was a statistically significant difference in the absolute lymphocyte count between influenza A and RSV (p = 0.002). The median number of days in hospital was 6 days (Q1-Q3: 4-10). Patients with RSV infection required a significantly longer hospital stay, with a median of 8 days (Q1-Q3: 4-10). The factors associated with the likelihood of PICU admission for all study participants were congenital heart disease (odds ratio (OR) = 2.9, 95% confidence intervals (CI) [1.4-6.1]), RSV (OR = 2.3, 95% CI [1.3-4.1]) and age <6 months (OR = 2.0, 95% CI [1.2-3.4]).

Conclusions: RSV was identified as the most common pathogen causing acute lower respiratory infections among the studied patients. One of the more significant findings to emerge from this study is the seasonal changes in RSV and influenza infections, which mandates further research.

背景:全球一致认为呼吸道感染是儿童发病和死亡的主要原因。在本研究中,我们旨在比较急性呼吸道感染住院儿童呼吸道合胞病毒(RSV)、流感和严重急性呼吸道综合征冠状病毒2 (SARS-CoV-2)感染的临床和流行病学特征。我们还选择确定儿科重症监护病房(PICU)入院的预测因素。方法:本研究对沙特阿拉伯南部地区Abha妇幼医院于2022年1月至12月收治的423名儿童进行回顾性调查和分析。结果:患儿的中位年龄为16.5个月(Q1-Q3: 6-46.3)。RSV、SARS-CoV-2、甲型流感和乙型流感感染高峰期分别出现在9月初至中旬、7月中旬、5月至6月和10月。RSV与乙型流感(p = 0.035)、SARS-CoV-2与乙型流感(p = 0.013)的白细胞总数比较,差异有统计学意义。此外,流感a和RSV患者的绝对淋巴细胞计数差异有统计学意义(p = 0.002)。住院天数中位数为6天(Q1-Q3: 4-10)。RSV感染患者需要更长的住院时间,中位数为8天(Q1-Q3: 4-10)。与所有研究参与者PICU入院可能性相关的因素是先天性心脏病(优势比(OR) = 2.9, 95%可信区间(CI)[1.4-6.1])、RSV (OR = 2.3, 95% CI[1.3-4.1])和年龄。结论:RSV是研究患者中引起急性下呼吸道感染最常见的病原体。这项研究得出的一个更重要的发现是呼吸道合胞病毒和流感感染的季节性变化,这需要进一步的研究。
{"title":"Clinical and epidemiological characteristics of respiratory syncytial virus, SARS-CoV-2 and influenza paediatric viral respiratory infections in southwest Saudi Arabia.","authors":"Ali Alsuheel Asseri, Saleh M Al-Qahtani, Ibrahim A Alzaydani, Ahmed Al-Jarie, Noha Saad Alyazidi, Ali A Alrmelawi, Alya Musfer Alqahtani, Rahaf S Alsulayyim, Ameerah K Alzailaie, Dhay M Abdullah, Abdelwahid S Ali","doi":"10.1080/07853890.2024.2445791","DOIUrl":"https://doi.org/10.1080/07853890.2024.2445791","url":null,"abstract":"<p><strong>Background: </strong>There is a global consensus that respiratory tract infections are the major causes of morbidity and mortality among children. In this study, we aimed to compare the clinical and epidemiological characteristics of respiratory syncytial virus (RSV), influenza and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections among children admitted to hospital with acute respiratory infections. We also opted to identify the predictors of paediatric intensive care unit (PICU) admission.</p><p><strong>Methods: </strong>In this study, a retrospective investigation and analysis of 423 children who were admitted to Abha Maternity and Children Hospital, in the southern region of Saudi Arabia, between January and December 2022 were conducted.</p><p><strong>Results: </strong>The median age of these children was 16.5 months (Q1-Q3: 6-46.3). It was observed that the infectivity levels of RSV, SARS-CoV-2, influenza A and influenza B infections peaked in early to mid-September, mid-July, May and June, and October, respectively. There was a statistically significant difference in the total WBC counts between RSV and influenza B (<i>p</i> = 0.035) and SARS-CoV-2 and influenza B (<i>p</i> = 0.013). Moreover, there was a statistically significant difference in the absolute lymphocyte count between influenza A and RSV (<i>p</i> = 0.002). The median number of days in hospital was 6 days (Q1-Q3: 4-10). Patients with RSV infection required a significantly longer hospital stay, with a median of 8 days (Q1-Q3: 4-10). The factors associated with the likelihood of PICU admission for all study participants were congenital heart disease (odds ratio (OR) = 2.9, 95% confidence intervals (CI) [1.4-6.1]), RSV (OR = 2.3, 95% CI [1.3-4.1]) and age <6 months (OR = 2.0, 95% CI [1.2-3.4]).</p><p><strong>Conclusions: </strong>RSV was identified as the most common pathogen causing acute lower respiratory infections among the studied patients. One of the more significant findings to emerge from this study is the seasonal changes in RSV and influenza infections, which mandates further research.</p>","PeriodicalId":93874,"journal":{"name":"Annals of medicine","volume":"57 1","pages":"2445791"},"PeriodicalIF":0.0,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142883837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
全部 ACS Applied Bio Materials MEDCHEMCOMM Mol. Biosyst. Anal. Chim. Acta X Biosens. Bioelectron. X Chem. Data Collect. Curr. Res. Green Sustain. Chem. EnergyChem Results Chem. Sens. Bio-Sens. Res. Sens. Actuators Rep. Talanta Open IEEE Open J. Nanotechnol. Adv. Struct. Chem. Imag. Appl. Adhes. Sci. Appl. Microsc. Appl. Petrochem. Res. Arabian J. Geosci. BENI-SUEF U J BASIC BMC Mol. Biol. BMC Struct. Biol. Bull. Russ. Acad. Sci. Phys. Catal. Ind. Coke Chem. EJNMMI Radiopharm. Chem. Energy Inform. Future J. Pharm. Sci. Inorg. Mater. Appl. Res. Int. J. Mech. Mater. Eng. Int. J. Self-Propag. High-Temp. Synth. J. Appl. Ind. Math. J. Mach. Manuf. Reliab. J SURF INVEST-X-RAY+ Mater. Renew. Sustain. Energy Membr. Membr. Technol. Micro Nano Syst. Lett. Moscow Univ. Chem. Bull. Moscow Univ. Mech. Bull. Nanoscale Res. Lett. Nanotechnol. Russia Opt. Mem. Neural Networks Phys. Part. Nuclei Lett. Radiochemistry Surf. Eng. Appl. Electrochem. Therm. Eng. 2007 IEEE Aerospace Conference 2011 International Conference on Remote Sensing, Environment and Transportation Engineering 2012 IEEE 16th International Symposium on Consumer Electronics 1 2008 3rd International Conference on Sensing Technology 2012 IEEE 32nd International Conference on Distributed Computing Systems 2010 International Conference on E-Product E-Service and E-Entertainment 2012 Fourth International Workshop on Quality of Multimedia Experience 2013 9th Asian Control Conference (ASCC) 2003 IEEE Topical Conference on Wireless Communication Technology 2007 25th International Conference on Computer Design 2008 IEEE/OES US/EU-Baltic International Symposium 2012 IEEE MTT-S International Microwave Workshop Series on Innovative Wireless Power Transmission: Technologies, Systems, and Applications 2012 XXth International Conference on Electrical Machines 2013 Design, Automation & Test in Europe Conference & Exhibition (DATE) 2013 IEEE International Symposium on Broadband Multimedia Systems and Broadcasting (BMSB) 2013 11th IEEE International Conference on Industrial Informatics (INDIN) 2013 Abstracts IEEE International Conference on Plasma Science (ICOPS) "Laboratorio;" analisis clinicos, bacteriologia, inmunologia, parasitologia, hematologia, anatomia patologica, quimica clinica "Radiation and Risk" Bulletin of the National Radiation and Epidemiological Registry 2011 IEEE 2nd International Conference on Computing, Control and Industrial Engineering 2011 Annual Report Conference on Electrical Insulation and Dielectric Phenomena 2012 38th IEEE Photovoltaic Specialists Conference 2012 9th International Conference on Electrical Engineering/Electronics, Computer, Telecommunications and Information Technology 2013 IEEE MTT-S International Microwave Workshop Series on RF and Wireless Technologies for Biomedical and Healthcare Applications (IMWS-BIO) [1993] Proceedings Eighth Annual IEEE Symposium on Logic in Computer Science 2005 Asian Conference on Sensors and the International Conference on New Techniques in Pharmaceutical and Biomedical Research 2008 International Conference on Electronic Packaging Technology & High Density Packaging 2009 12th International Symposium on Design and Diagnostics of Electronic Circuits & Systems 2009 16th International Conference on Industrial Engineering and Engineering Management 2009 International Workshop on Intelligent Systems and Applications 2011 International Conference on Computer Distributed Control and Intelligent Environmental Monitoring 2011 VII Southern Conference on Programmable Logic (SPL) 2013 Fourth International Conference on Computing, Communications and Networking Technologies (ICCCNT) 2011 Conference on Lasers and Electro-Optics Europe and 12th European Quantum Electronics Conference (CLEO EUROPE/EQEC) 2012 IEEE International Conference on Oxide Materials for Electronic Engineering (OMEE) 2012 IEEE/ACM Sixth International Symposium on Networks-on-Chip 2013 International Conference on Optical MEMS and Nanophotonics (OMN) [Sanfujinka chiryo] Obstetrical and gynecological therapy 2011 International Conference on Electrical and Control Engineering 2013 IEEE International Symposium on Hardware-Oriented Security and Trust (HOST) [Hokkaido igaku zasshi] The Hokkaido journal of medical science «Узбекский физический журнал» 2011 International Conference on Electric Technology and Civil Engineering (ICETCE) 2012 IEEE International Workshop on Antenna Technology (iWAT) 2013 21st IEEE International Requirements Engineering Conference (RE) 2013 IEEE Conference on Computer Vision and Pattern Recognition 2009 IEEE Congress on Evolutionary Computation 2011 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW) 2012 SC Companion: High Performance Computing, Networking Storage and Analysis 2012 Symposium on VLSI Circuits (VLSIC) 2009 International Conference on Energy and Environment Technology 2010 International Conference on Mechanic Automation and Control Engineering 2013 IEEE 39th Photovoltaic Specialists Conference (PVSC) 2013 IEEE International Conference on Computer Vision
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1